Pharmaceutical company Novartis has filed a lawsuit against the HHS over the way drugs are priced under the 340B program.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Novartis sues HHS over 340B pricing model
Pharmaceutical company Novartis has filed a lawsuit against the HHS over the way drugs are priced under the 340B program.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis